
Drug Utilization Research
Methods and Applications
Wiley (Publisher)
2nd Edition
Published on 19. September 2024
Book
Hardback
624 pages
978-1-119-91165-4 (ISBN)
Description
Towards a better understanding of how medicines are used in society
Drug Utilization Research (DUR) is a discipline which combines aspects of pharmacotherapy, epidemiology, and health services research into an interdisciplinary set of methods for analyzing and assessing the prescribing, dispensing and consumption of medicines. It combines both qualitative and quantitative approaches to facilitate the safe and effective use of pharmaceuticals. Drug Utilization Research: Methods and Applications provides a comprehensive introduction to this discipline, prepared by an international team of authors with broad experience in numerous fields. Now reorganized and updated to reflect the latest research and global challenges, it is an indispensable resource for understanding the use of pharmaceuticals.
Readers of the second edition of Drug Utilization Research will find:
New chapters on methods, including more hands-on guidance on how to plan and conduct different types of drug utilization
A section on specific applications in areas such as psychotropics, opioids, cancer drugs, antibacterials, and cardiovascular drugs
A new section with case studies illustrating applications of DUR in different continents
Detailed treatment of subjects including DUR and health policy, DUR in specific populations, and many more
Drug Utilization Research is ideal for epidemiologists, pharmacists, physicians, nurses and others interested in drug use and its outcomes.
Drug Utilization Research (DUR) is a discipline which combines aspects of pharmacotherapy, epidemiology, and health services research into an interdisciplinary set of methods for analyzing and assessing the prescribing, dispensing and consumption of medicines. It combines both qualitative and quantitative approaches to facilitate the safe and effective use of pharmaceuticals. Drug Utilization Research: Methods and Applications provides a comprehensive introduction to this discipline, prepared by an international team of authors with broad experience in numerous fields. Now reorganized and updated to reflect the latest research and global challenges, it is an indispensable resource for understanding the use of pharmaceuticals.
Readers of the second edition of Drug Utilization Research will find:
New chapters on methods, including more hands-on guidance on how to plan and conduct different types of drug utilization
A section on specific applications in areas such as psychotropics, opioids, cancer drugs, antibacterials, and cardiovascular drugs
A new section with case studies illustrating applications of DUR in different continents
Detailed treatment of subjects including DUR and health policy, DUR in specific populations, and many more
Drug Utilization Research is ideal for epidemiologists, pharmacists, physicians, nurses and others interested in drug use and its outcomes.
More details
Edition
2nd edition
Language
English
Place of publication
New York
United States
Target group
Professional and scholarly
Dimensions
Height: 249 mm
Width: 201 mm
Thickness: 38 mm
Weight
1701 gr
ISBN-13
978-1-119-91165-4 (9781119911654)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

Monique Elseviers | Sean Macbride-Stewart | Elisabetta Poluzzi
Drug Utilization Research
Methods and Applications
E-Book
09/2024
2nd Edition
Wiley-ISTE
€134.99
Available for download

Monique Elseviers | Sean Macbride-Stewart | Elisabetta Poluzzi
Drug Utilization Research
Methods and Applications
E-Book
08/2024
2nd Edition
Wiley-ISTE
€134.99
Available for download
Previous edition

Monique Elseviers | Björn Wettermark | Anna Birna Almarsdóttir
Drug Utilization Research
Methods and Applications
Book
05/2016
Wiley
€129.00
Article exhausted; check for reprint
Persons
Monique Elseviers, Department of Clinical Pharmacology, Ghent University, Belgium; Centre for Research and Innovation in Care, Faculty of Medicine and Health Sciences, University of Antwerp, Belgium.
Bjoern Wettermark, Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University, Sweden.
Tanja Mueller, Strathclyde Institute of Pharmacy and Biomedical Studies, University of Strathclyde, Scotland, United Kingdom.
Ria Benkoe, Department of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, Hungary.
Marion Bennie, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Scotland, United Kingdom.
Katarina Gvozdanovic, Agency for Medical Products and Medical Devices, Zagreb, Croatia; School of Medicine, University of Zagreb, Croatia.
Mikael Hoffmann, The NEPI Foundation, Stockholm & Division of Society and Health, Department of Health, Medicine and Caring Sciences (HMV), Linkoeping University, Sweden.
Irina Iaru, Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Romania.
Verica Ivanovska, World Health Organization, Geneva, Switzerland.
Sean MacBride-Stewart, Pharmacy Services, NHS Greater Glasgow & Clyde, Scotland, United Kingdom.
Elisabetta Poluzzi, Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Italy.
Lisa Pont, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Australia.
Hege Salvesen Blix, WHO Collaborating Centre for Drug Statistics Methodology, Department of Drug Statistics, Norwegian Institute of Public Health, Norway.
Gabriel Sanfelix-Gimeno, Health Services Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Spain.
Gisbert Selke, AOK Research Institute (WIdO), Germany.
Katja Taxis, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, The Netherlands.
Ana Tomas Petrovic, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine Novi Sad, University of Novi Sad, Serbia.
Indre Treciokiene, Pharmacy Center, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Lithuania.
Sabine Vogler, WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Austrian National Public Health Institute, Austria.
Bjoern Wettermark, Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University, Sweden.
Tanja Mueller, Strathclyde Institute of Pharmacy and Biomedical Studies, University of Strathclyde, Scotland, United Kingdom.
Ria Benkoe, Department of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, Hungary.
Marion Bennie, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Scotland, United Kingdom.
Katarina Gvozdanovic, Agency for Medical Products and Medical Devices, Zagreb, Croatia; School of Medicine, University of Zagreb, Croatia.
Mikael Hoffmann, The NEPI Foundation, Stockholm & Division of Society and Health, Department of Health, Medicine and Caring Sciences (HMV), Linkoeping University, Sweden.
Irina Iaru, Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Romania.
Verica Ivanovska, World Health Organization, Geneva, Switzerland.
Sean MacBride-Stewart, Pharmacy Services, NHS Greater Glasgow & Clyde, Scotland, United Kingdom.
Elisabetta Poluzzi, Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Italy.
Lisa Pont, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Australia.
Hege Salvesen Blix, WHO Collaborating Centre for Drug Statistics Methodology, Department of Drug Statistics, Norwegian Institute of Public Health, Norway.
Gabriel Sanfelix-Gimeno, Health Services Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Spain.
Gisbert Selke, AOK Research Institute (WIdO), Germany.
Katja Taxis, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, The Netherlands.
Ana Tomas Petrovic, Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine Novi Sad, University of Novi Sad, Serbia.
Indre Treciokiene, Pharmacy Center, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Lithuania.
Sabine Vogler, WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Austrian National Public Health Institute, Austria.
Editor
University of Antwerp, Belgium
Uppsala University, Sweden
University of Strathclyde, Scotland, UK
University of Strathclyde, UK
University of Zagreb, Croatia
Linkoping University, Sweden
University of Medicine and Pharmacy Cluj-Napoca, Romania
World Health Organization, Geneva, Switzerland
NHS Greater Glasgow & Clyde, Scotland, UK